{"id":542350,"date":"2026-07-27T16:33:26","date_gmt":"2026-07-27T16:33:26","guid":{"rendered":"https:\/\/www.newjerseyheadlines.com\/news\/story\/542350\/point-of-care-diagnostics-market-to-reach-3146-billion-by-2031-driven-by-rising-demand-for-rapid-and-decentralized-testing.html"},"modified":"2026-07-27T16:33:26","modified_gmt":"2026-07-27T16:33:26","slug":"point-of-care-diagnostics-market-to-reach-3146-billion-by-2031-driven-by-rising-demand-for-rapid-and-decentralized-testing","status":"publish","type":"post","link":"http:\/\/www.northcarolinaheadlines.com\/news\/story\/542350\/point-of-care-diagnostics-market-to-reach-3146-billion-by-2031-driven-by-rising-demand-for-rapid-and-decentralized-testing.html","title":{"rendered":"Point of Care Diagnostics Market to Reach $31.46 Billion by 2031, Driven by Rising Demand for Rapid and Decentralized Testing"},"content":{"rendered":"
\"Point<\/a><\/div>\n
Point of Care Diagnostics Market by Product (Glucose, Infectious Disease [TB, HAI, STD], Pregnancy), Purchase Mode (Rx, OTC), Technology (Biochemistry, MDx [RT-PCR, INAAT]), Sample (Blood, Urine), End User (Home Care, Hospitals) – Global Forecast to 2031<\/div>\n

According to MarketsandMarkets™, <\/strong>The global point of care diagnostics market<\/a><\/strong> is projected to grow from USD 20.63 billion in 2026 to USD 31.46 billion by 2031, at a CAGR of 8.8% during the forecast period. Market growth is primarily driven by the increasing prevalence of chronic and infectious diseases, along with the growing need for rapid, accurate, and decentralized diagnostic solutions.<\/p>\n

Browse 250 market data Tables and 100 Figures spread through 300 Pages and in-depth TOC on “Point of Care Diagnostics Market”.<\/strong><\/p>\n

Download PDF Brochure: https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=106829185<\/a><\/strong><\/p>\n

Rising incidences of diabetes, cardiovascular diseases, respiratory infections, and other acute and chronic conditions are fueling demand for point-of-care testing across healthcare settings. POC diagnostic devices including blood glucose monitors, rapid antigen and molecular tests, cardiac biomarker analyzers, and pregnancy tests enable faster clinical decision-making and improved patient outcomes. Additionally, the growing shift toward decentralized healthcare, supported by telemedicine and digital health technologies, is accelerating adoption globally.<\/p>\n

Glucose Monitoring Products Lead Market<\/strong><\/p>\n

By product, glucose monitoring products accounted for the largest share of the point-of-care diagnostics market in 2025. This dominance is driven by the high global burden of diabetes, which requires continuous monitoring across hospitals, clinics, and home care settings.<\/p>\n

Advancements in glucose monitoring technologies, including continuous glucose monitoring (CGM) systems, smartphone-connected devices, improved biosensors, and cloud-based data integration, are enhancing accuracy and convenience. Increasing awareness of diabetes management and preventive healthcare is further supporting the growth of this segment.<\/p>\n

Clinical Laboratories Dominate End-User Segment<\/strong><\/p>\n

By end user, clinical laboratories held the largest share of the global point-of-care diagnostics market in 2025. Their central role in delivering high-volume, reliable diagnostic testing across multiple disease areas makes them a key driver of market demand.<\/p>\n

The expansion of laboratory networks, coupled with advancements in automation, portable diagnostic technologies, and digital data management systems, has significantly improved testing efficiency and turnaround times. Increasing investments in healthcare infrastructure and the growing emphasis on early disease detection further reinforce the segment’s leading position.<\/p>\n

Request Sample Pages: https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=106829185<\/a><\/strong><\/p>\n

Asia Pacific Emerges as Fastest-Growing Region<\/strong><\/p>\n

Asia Pacific is projected to register the highest growth rate in the point-of-care diagnostics market through 2031. Growth in the region is driven by a large and aging population, increasing prevalence of chronic and infectious diseases, and rising demand for accessible diagnostic solutions.<\/p>\n

Improvements in healthcare infrastructure, supportive government initiatives, and increasing healthcare expenditure are accelerating adoption. The growing trend toward home-based testing and community healthcare, along with advancements in portable and user-friendly diagnostic technologies, is further contributing to regional market expansion.<\/p>\n

Competitive Landscape<\/strong><\/p>\n

Key players operating in the point-of-care diagnostics market include Abbott Laboratories (US), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Siemens Healthineers AG (Germany), QuidelOrtho Corporation (US), bioMérieux SA (France), Werfen S.A. (Spain), Becton, Dickinson and Company (US), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific Inc. (US), OraSure Technologies, Inc. (US), EKE Diagnostics (China), Trinity Biotech plc (Ireland), Grifols S.A. (Spain), Nova Biomedical Corporation (US), Sekisui Diagnostics, LLC (US), Trividia Health, Inc. (US), Sysmex Corporation (Japan), HemoCue AB (Sweden), and Bio-Rad Laboratories, Inc. (US), among others.<\/p>\n

These companies are focusing on product innovation, strategic partnerships, and global expansion to strengthen their market presence and meet the growing demand for rapid diagnostic solutions.<\/p>\n

Related Reports:<\/strong><\/p>\n

In Vitro Diagnostics Market<\/a> – Global Forecast to 2030<\/strong><\/p>\n

Veterinary PoC Diagnostics Market<\/a> – Global Forecast to 2031<\/strong><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> MarketsandMarkets\u2122 Research Private Ltd.<\/a>
Contact Person:<\/strong> Mr. Rohan Salgarkar
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 18886006441
Address:<\/strong>1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City:<\/strong> Florida
State:<\/strong> Florida
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.marketsandmarkets.com\/Market-Reports\/point-of-care-diagnostic-market-106829185.html<\/a><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Point of Care Diagnostics Market by Product (Glucose, Infectious Disease [TB, HAI, STD], Pregnancy), Purchase Mode (Rx, OTC), Technology (Biochemistry, MDx [RT-PCR, INAAT]), Sample (Blood, Urine), End User (Home Care,<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"_links":{"self":[{"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/posts\/542350"}],"collection":[{"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/comments?post=542350"}],"version-history":[{"count":0,"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/posts\/542350\/revisions"}],"wp:attachment":[{"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/media?parent=542350"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/categories?post=542350"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/tags?post=542350"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}